Seeing Is Believing
with an average price target of $29.21. This is a potential upside of $14.71 (101.45%) from yesterday's end of day stock price of $14.5.
Aligos Therapeutics 's activity chart (see below) currently has 11 price targets and 12 ratings on display.
Analysts average stock forecasts to be materialized ratio is 47.92% with an average time for these price targets to be met of 165.75 days.
Most recent stock forecast was given by YASMEEN RAHIMI from PIPER SANDLER on 06-Jan-2023. First documented stock forecast 10-Nov-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$50
$33.24 (198.33%)
$100
2 years 1 months 25 days ago
(06-Jan-2023)
1/6 (16.67%)
$17.25 (52.67%)
11
Buy
$50
$33.24 (198.33%)
$125
2 years 1 months 25 days ago
(06-Jan-2023)
3/4 (75%)
$17.25 (52.67%)
18
Hold
$6
$-6.68 (-52.68%)
$12
2 years 11 months 17 days ago
(14-Mar-2022)
3/3 (100%)
$3.55 (144.90%)
634
Buy
3 years 7 months 24 days ago
(08-Jul-2021)
0/2 (0%)
$20.8 (108.33%)
What is ALGS (Aligos Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on ALGS (Aligos Therapeutics ) with a proven track record?
Which analyst has the current lower performing score on ALGS (Aligos Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on ALGS (Aligos Therapeutics )?
Which analyst is the currently most bullish on ALGS (Aligos Therapeutics )?
Which analyst is the currently most reserved on ALGS (Aligos Therapeutics )?